Abstract:ObjectiveTo investigate the detection and change in drugresistance of extendedspectrum βlactamase (ESBLs)producing Escherichia coli, so as to provide reference for the rational use of antimicrobial agents in clinic.MethodsEscherichia coli isolated from clinic in a hospital between January~December, 2006 were collected, the detection of ESBLs and drugresistance were compared with those of 2002. ResultsThe rate of ESBLsproducing Escherichia coli isolated in 2006 was 65.54% (175/267), which increased obviously compared with 47.92% (46/96) isolated in 2002 (χ2=9.21, P<0.05). The susceptibility rate of ESBLsproducing Escherichia coli to imipenem in 2006 was 24.00%, which decreased obviously compared with 52.17% in 2002 (χ2=13.80, P<0.05); The susceptibility rates to the other antimicrobial agents had no statistic significance, imipenem still had ideal activity against ESBLsproducing Escherichia coli. ConclusionThere is increasing tendency in the detection of ESBLsproducing Escherichia coli, and drugresistance is high, which should be paid attention.